Free shipping on all orders over $ 500

ERD-3111

Cat. No. M43413

All AbMole products are for research use only, cannot be used for human consumption.

ERD-3111 Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

ERD-3111 is an orally active PROTAC ERα degrader (DC50: 0.5 nM).

Chemical Information
Molecular Weight 854.89
Formula C45H46F4N8O5
CAS Number 2832865-25-3
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhixiang Chen et al. J Med Chem. Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity

Related Estrogen Receptor Products
Fulvestrant

Fulvestrant is a Estrogen receptor (ER) antagonist with IC50 of 0.094 nM. Fulvestrant can also induce autophagy and apoptosis, and has anti-tumor effect.

LY500307

LY500307 is a potent, selective estrogen receptor beta agonist with an EC50 of 0.66 nM.

Calcitriol

Calcitriol is an Active metabolite of vitamin D3 that activates the vitamin D receptor. *The compound is unstable in solutions, freshly prepared is recommended

Tamoxifen Citrate (ICI 46474)

Tamoxifen Citrate is an antagonist of the estrogen receptor by competitive inhibition of estrogen binding.

20-Hydroxyecdysone

20-Hydroxyecdysone (Ecdysterone, 20E) is a naturally occurring ecdysteroid hormone which controls the ecdysis (moulting) and metamorphosis of arthropods.

  Catalog
Abmole Inhibitor Catalog




Keywords: ERD-3111 supplier, Estrogen Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.